Serum albumin is a useful prognostic indicator and adds important information to NT-proBNP in a Chinese cohort of heart failure

Clinical Biochemistry

Volumn 45, Issue 7-8, 2012, Pages 561-565

  Su, Wenting ^a   An, Tao ^a   Zhou, Qiong ^a   Huang, Yan ^a   Zhang, Jian ^a   Zhang, Yuhui ^a   Wei, Bingqi ^a   Sun, Xiaolu ^a   Zou, Changhong ^a   Lou, Kejia ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Heart failure; NT proBNP; Prognosis; Serum albumin

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CHINESE; COHORT ANALYSIS; DISEASE EXACERBATION; FEMALE; HEART FAILURE; HUMAN; HYPOALBUMINEMIA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; UNIVARIATE ANALYSIS;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SERUM ALBUMIN;

EID: 84862796467     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.02.010     Document Type: Article

References (37)

1. Batin P., Wickens M., McEntegart D., Fullwood L., Cowley A.J. The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. Eur Heart J 1995, 16:1613-1618.
2. Branwood A.W. Some observations on liver function in heart failure. Edinb Med J 1950, 57:129-138.
3. Jolliffe N. Liver function in congestive heart failure. J Clin Invest 1930, 8:419-433.
4. Lee S.Y. Liver function in congestive heart failure. Taehan Naekwa Hakhoe Chapchi 1963, 6:183-185.
5. Arques S. Hypoalbuminemia as a risk factor of incident heart failure in the elderly. Am Heart J 2010, 160:e39-e41.
6. Ganotakis E.S., Vrentzos G.E., Gazi I.F., Papadakis J.A., Jagroop A., Paraskevas K.I., et al. Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels and cardiovascular risk calculated using the Framingham equation. In Vivo 2007, 21:685-694.
7. Gopal D.M., Kalogeropoulos A.P., Georgiopoulou V.V., Tang W.W., Methvin A., Smith A.L., et al. Serum albumin concentration and heart failure risk The Health, Aging, and Body Composition Study. Am Heart J 2010, 160:279-285.
8. Arques S., Roux E., Sbragia P., Gelisse R., Pieri B., Ambrosi P. Usefulness of serum albumin concentration for in-hospital risk stratification in frail, elderly patients with acute heart failure. Insights from a prospective, monocenter study. Int J Cardiol 2008, 125:265-267.
9. Horwich T.B., Kalantar-Zadeh K., MacLellan R.W., Fonarow G.C. Albumin levels predict survival in patients with systolic heart failure. Am Heart J 2008, 155:883-889.
10. Shinagawa H., Inomata T., Koitabashi T., Nakano H., Takeuchi I., Naruke T., et al. Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure. Circ J 2008, 72:364-369.
11. Dieplinger B., Gegenhuber A., Struck J., Poelz W., Langsteger W., Haltmayer M., et al. Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure. Clin Chim Acta 2009, 400:91-96.
12. Felder L., Mund A., Parker J.G. Liver function tests in chronic congestive heart failure. Circulation 1950, 2:286-297.
13. Keida Y., Takegoshi K., Fukazawa T., Shimada H., Matsuda T. Disturbance of liver function in chronic congestive heart failure. Nippon Ronen Igakkai Zasshi 1982, 19:293-298.
14. Kumada T., Himura Y., Iwata T., Nakamura Y., Fukuda Y., Fujiwara H., et al. Liver function in congestive heart failure: abnormal elevation of serum hepatic enzyme and hepatic venous flow velocity. Jpn Circ J 1989, 53:165-174.
15. Lau G.T., Tan H.C., Kritharides L. Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol 2002, 90:1405-1409.
16. Moore C.B. Liver function tests in congestive heart failure. J La State Med Soc 1960, 112:208-215.
17. van Deursen V.M., Damman K., Hillege H.L., van Beek A.P., van Veldhuisen D.J., Voors A.A. Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Card Fail 2010, 16:84-90.
18. Szygula-Jurkiewicz B., Wojnicz R., Lekston A., Duszanska A., Spinczyk B., Nowak J., et al. Effect of elevated bilirubin levels on the long-term outcome in patients with chronic heart failure due to hypertension. Pol Arch Med Wewn 2007, 117:227-233.
19. Allen L.A., Felker G.M., Pocock S., McMurray J.J., Pfeffer M.A., Swedberg K., et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail 2009, 11:170-177.
20. Ess M., Mussner-Seeber C., Mariacher S., Lorsbach-Koehler A., Pachinger O., Frick M., et al. Gamma-glutamyltransferase rather than total bilirubin predicts outcome in chronic heart failure. J Card Fail 2011, 17:577-584.
21. Uthamalingam S., Kandala J., Daley M., Patvardhan E., Capodilupo R., Moore S.A., et al. Serum albumin and mortality in acutely decompensated heart failure. Am Heart J 2010, 160:1149-1155.
22. Novack V., Pencina M., Zahger D., Fuchs L., Nevzorov R., Jotkowitz A., et al. Routine laboratory results and thirty day and one-year mortality risk following hospitalization with acute decompensated heart failure. PLoS One 2010, 5:e12184.
23. Hartopo A.B., Gharini P.P., Setianto B.Y. Low serum albumin levels and in-hospital adverse outcomes in acute coronary syndrome. Int Heart J 2010, 51:221-226.
24. Chojkier M. Inhibition of albumin synthesis in chronic diseases: molecular mechanisms. J Clin Gastroenterol 2005, 39:S143-S146.
25. De Feo P., Horber F.F., Haymond M.W. Meal stimulation of albumin synthesis: a significant contributor to whole body protein synthesis in humans. Am J Physiol 1992, 263:E794-E799.
26. Hesse B., Parving H.H., Lund-Jacobsen H., Noer I. Transcapillary escape rate of albumin and right atrial pressure in chronic congestive heart failure before and after treatment. Circ Res 1976, 39:358-362.
27. Ross R.S., Walker W.G., Hammond J.D. Distribution and transcapillary exchange of albumin in congestive heart failure. Circ Res 1960, 8:1041-1048.
28. Masson S., Latini R., Milani V., Moretti L., Rossi M.G., Carbonieri E., et al. Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure trial. Circ Heart Fail 2010, 3:65-72.
29. Hara N., Nagashima A., Yoshida T., Furukawa T., Inokuchi K. Effect of decreased plasma colloid osmotic pressure on development of pulmonary edema in dogs. Jpn J Surg 1981, 11:203-208.
30. Parker J.C. Hydraulic conductance of lung endothelial phenotypes and Starling safety factors against edema. Am J Physiol Lung Cell Mol Physiol 2007, 292:L378-L380.
31. Kaplan E., Puestow R.C., Baker L.A., Kruger S. Blood volume in congestive heart failure as determined with iodinated human serum albumin. Am Heart J 1954, 47:824-838.
32. Roche M., Rondeau P., Singh N.R., Tarnus E., Bourdon E. The antioxidant properties of serum albumin. FEBS Lett 2008, 582:1783-1787.
33. Arques S., Ambrosi P. Human serum albumin in the clinical syndrome of heart failure. J Card Fail 2011, 17:451-458.
34. Wilson Tang W., Francis G.S., Morrow D.A., Newby L.K., Cannon C.P., Jesse R.L., et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Circulation 2007, 116:e99-e109.
35. Adams K., Lindenfeld J., Arnold J.M.O., Baker D., Barnard D., Baughman K., et al. HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 2006, 12:e86-e103.
36. Braunwald E. Biomarkers in heart failure. N Engl J Med 2008, 358:2148-2159.
37. Seino Y., Ogawa A., Yamashita T., Fukushima M., Ogata K., Fukumoto H., et al. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail 2004, 6:295-300.